|
ChinaBio® Investor Forum 2010 - Shanghai
|
|
Tuesday, May 18, 2010
|
|
17:30 - 19:30
|
Welcome Reception
Meet with speakers and other attendees at this informal reception
|
Z Bar, 2F, Howard Johnson Hotel - Zhangjiang
|
|
Day 1 - Wednesday, May 19, 2010
|
|
Time
|
Title/Description
|
Speakers/Presenters
|
|
08:00 - 09:00
|
Registration and Refreshments
|
|
|
09:00 - 09:30
|
Welcome Remarks
|
Greg B. Scott - President & Founder, ChinaBio® LLC
|
|
Lanzhong Wang - Gereral Manager, Shanghai Zhangjiang Biotech & Pharmaceutical Base Development Co., Ltd.
|
|
09:30 - 10:00
|
Keynote 1: BioPharmaceutical Innovation in Zhangjiang
Zhangjiang Hi-Tech Park in Shanghai is considered to be the center if biopharmaceutical innovation in China. Nearly all of the big pharma have elected to invest significantly in R&D centers here, and many of the innovative drugs and products being commercialized in China have come from Zhangjiang and surrounding areas. Hear one of the true pioneers of the biopharmaceutical industry in China describe how China and Zhangjiang have advanced since the 1980s, and what lies in store in the future.
|
William Keller - Vice GM/Chairman, Shanghai Zhangjiang Biotech & Pharmaceutical Base Development Co., Ltd. / HBM BioMed China
|
|
10:00 - 10:30
|
Keynote 2: Life Science Funding Trends
Investment in early and mid-stage life science companies in China is growing rapidly. VCs are moving from the service sector to innovative companies doing drug development, diagnostics and medical devices. Central and local government agencies are pouring billions of dollars into life science technology development and healthcare reform. Hear where funding is flowing in China, and how the investment environment is changing.
|
Greg B. Scott - President & Founder, ChinaBio® LLC
|
|
10:30 - 11:00
|
Break and Refreshments
|
|
|
11:00 - 12:00
|
Panel 1: How to Get VCs to Part with Their Money
There is a humorous expression describing venture capitalists - they have deep pockets but short arms. If you want a VC to reach deep into his pockets and invest in your company, you must have a compelling story - the first and best technology to address a large market is always a good place to start. Some of the most active VCs in China life science will tell you what they’re looking for in technologies and management teams, what you need to do to get them to part with their money.
|
Moderator:
Tao Xiong, JD - Partner, Broad & Bright
|
|
Panelists:
Yi Shi, PhD, MBA - Managing Director, Lilly Asian Ventures
|
|
David Xu, PhD, MBA - Managing Partner, Mingly China Growth Fund
|
|
Yanning Yi, MBA - Executive Director, The Balloch Group
|
|
Jonathan Wang, PhD, MBA - Senior Managing Director, OrbiMed Asia
|
|
12:00 - 13:30
|
Luncheon
|
|
|
13:30 - 14:30
|
Panel 2: Where to Locate Your Company
There are nearly 60 life science parks in China offering incentives and potential investment to attract your company to locate there. There are well recognized parks like Zhangjiang Hi-Tech Park in Shanghai, considered to be the hub of the biopharmaceutical industry in China, but there are also other parks rapidly positioning themselves for success. See executives from successful companies give straight talk on the parks’ programs and the real benefits they’ve experienced.
|
Moderator:
Greg B. Scott - President & Founder, ChinaBio® LLC
|
|
Panelists:
William Pan, PhD - Co-Founder & COO, Crown Bioscience, Inc.
|
|
Xiaochuan Wang, PhD - Chairman & CEO, Sundia MediTech Co., Ltd.
|
|
Jingyang Zhu, PhD - Senior Vice President of Global Technical Operations, Chiral Quest
|
|
Tao Zhu, PhD - Co-Founder & Executive VP, Vaccine Development, Tianjin CanSino Biotechnology Inc.
|
|
14:30 - 17:00
|
Company Presentations
Presenting companies from Shanghai and Greater China will be selected based on the strength of their technology, team and business model. Candidates will include drug development, medical device, diagnostics and research tool companies. Up to 8 companies will present in each session.
|
8 companies (Two Tracks)
|
|
17:00 - 18:00
|
Shuttle Buses to Gala Banquet
|
|
|
18:00 - 20:00
|
Gala Banquet - Herbal Legend Restaurant
|
|
|
Day 2 - Thursday, May 20, 2010
|
|
Time
|
Title/Description
|
Speakers/Presenters
|
|
08:30 - 09:30
|
Registration and Refreshments
|
|
|
09:30 - 10:30
|
Panel 3: Corporate Funding Opportunities
As big pharma and other large life science companies are looking to China to provide technology and marketing opportunities, more cross-border co-development, collaboration, M&A and partnerships are being announced in China. These deals can provide an alternative means of financing for early to late stage companies. Hear executives from big pharma describe the types of programs they are seeking and how they can help with funding.
|
Moderator:
Catherine Sun, LLM - Managing Partner, Foley & Lardner LLP
|
|
Panelists:
Robert W. Armstrong, PhD - Vice President, Global External R&D, Eli Lilly and Company
|
|
Alex Fowkes, JD - Executive Director, Head of R&D Business Development, Pfizer Global Research & Development
|
|
Jennifer Hu, PhD - Director of Licensing & External Research, Merck & Co., Inc., USA
|
|
Stella Xu, PhD - Executive Director, Roche Global Pharma Partnering
|
|
10:30 - 11:00
|
Break and Refreshments
|
|
|
11:00 - 12:00
|
Panel 4: Funding Success Stories
Autek Bio raised $100M US from Suma Ventures and government sources this year, and Suzhou Natong Nanobiotechnology received 20M RMB from Softbank. Learn how the senior executives of these firms attracted funding, and what it took to get the deal closed.
|
Moderator:
Adam Kearney, JD - Of Counsel, Morrison & Foerster
|
|
Panelists:
Julius Li, MBA - Co-Founder and CEO, AutekBio, Inc.
|
|
Chuck Ng - Managing Director, Suma Ventures
|
|
Bai Xu, PhD - President & CEO, Suzhou Natong Nanobiotechnology Co., Ltd.
|
|
12:00 - 13:30
|
Luncheon
|
|
|
13:30 - 16:00
|
Company Presentations
Presenting companies from Guangzhou and Greater China will be selected based on the strength of their technology, team and business model. Candidates will include drug development, medical device, diagnostics and research tool companies. Up to 8 companies will present in each session.
|
8 companies (Two Tracks)
|
|
16:00 - 16:30
|
Raffle Drawings - Win valuable prizes (including Shanghai Expo Tickets)
|
|
|
16:30 - 17:00
|
Award Ceremony / Closing Remarks
|
|
|
17:00 - 17:30
|
Closing Reception
|
|